Float Short %

2.97

Margin Of Safety %

Put/Call OI Ratio

0.23

EPS Next Q Diff

0.01

EPS Last/This Y

EPS This/Next Y

0.18

Price

11.11

Target Price

18.92

Analyst Recom

1.67

Performance Q

-26.05

Relative Volume

1.98

Beta

1.23

Ticker: NEO

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	NEO	14.65	0.31	0.01	17171
2025-01-24	NEO	14.86	0.30	0.00	17591
2025-01-27	NEO	15.04	0.30	0.00	17659
2025-01-28	NEO	15.19	0.30	0.40	17657
2025-01-29	NEO	14.58	0.30	0.10	17692
2025-01-30	NEO	14.79	0.29	0.00	17863
2025-01-31	NEO	14.29	0.30	0.00	17736
2025-02-03	NEO	13.88	0.29	0.98	18046
2025-02-04	NEO	14	0.31	0.51	18171
2025-02-05	NEO	14.08	0.31	0.00	18273
2025-02-06	NEO	13.48	0.29	0.01	19164
2025-02-07	NEO	13.44	0.31	0.15	18532
2025-02-10	NEO	13.53	0.31	0.01	19019
2025-02-11	NEO	13.47	0.30	0.00	19249
2025-02-12	NEO	13.79	0.31	0.01	18903
2025-02-13	NEO	13.97	0.31	0.00	18942
2025-02-14	NEO	14.43	0.31	0.06	18902
2025-02-18	NEO	12.41	0.30	0.27	19275
2025-02-19	NEO	12.72	0.28	0.17	21893
2025-02-20	NEO	11.84	0.28	0.05	22018
2025-02-21	NEO	11.1	0.23	3.10	21459
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	NEO	14.66	-4.8	-	0.10
2025-01-24	NEO	14.86	-4.8	-	0.10
2025-01-27	NEO	15.05	-4.8	-	0.10
2025-01-28	NEO	15.19	-4.8	-	0.10
2025-01-29	NEO	14.59	-4.8	-	0.10
2025-01-30	NEO	14.80	-4.8	-	0.10
2025-01-31	NEO	14.28	-4.8	-	0.10
2025-02-03	NEO	13.88	-4.8	-	0.10
2025-02-04	NEO	13.95	-4.8	-	0.10
2025-02-05	NEO	14.08	-4.8	-	0.10
2025-02-06	NEO	13.47	-4.8	-	0.10
2025-02-07	NEO	13.45	-4.8	-	0.10
2025-02-10	NEO	13.51	-4.8	-	0.10
2025-02-11	NEO	13.48	-4.8	-	0.10
2025-02-12	NEO	13.78	-4.8	-	0.10
2025-02-13	NEO	13.91	-4.8	-	0.10
2025-02-14	NEO	14.42	-4.8	-	0.10
2025-02-18	NEO	12.40	-4.8	-	0.10
2025-02-19	NEO	12.72	-4.8	-	0.10
2025-02-20	NEO	11.83	81.3	-	0.17
2025-02-21	NEO	11.11	72.8	-	0.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	NEO	-0.41	-2.45	3.04
2025-01-24	NEO	-0.41	-2.45	3.04
2025-01-27	NEO	-0.41	-2.53	3.04
2025-01-28	NEO	-0.41	-2.53	2.80
2025-01-29	NEO	-0.41	-2.53	2.80
2025-01-30	NEO	-0.41	-2.53	2.80
2025-01-31	NEO	-0.41	-2.53	2.80
2025-02-03	NEO	-0.41	-2.45	2.80
2025-02-04	NEO	-0.41	-2.45	2.80
2025-02-05	NEO	-0.41	-2.45	2.80
2025-02-06	NEO	-0.41	-2.45	2.80
2025-02-07	NEO	-0.41	-2.45	2.80
2025-02-10	NEO	-0.41	-2.45	2.80
2025-02-11	NEO	-0.40	-2.45	2.80
2025-02-12	NEO	-0.40	-2.45	2.97
2025-02-13	NEO	-0.40	-2.45	2.97
2025-02-14	NEO	-0.40	-2.45	2.97
2025-02-18	NEO	-0.40	-2.26	2.97
2025-02-19	NEO	-0.40	-2.26	2.97
2025-02-20	NEO	-0.33	-2.26	2.97
2025-02-21	NEO	-0.33	-2.26	2.97
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

-0.01

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

-0.33

Institutional Transactions

-2.26

Beta

1.23

Average Sales Estimate Current Quarter

171

Average Sales Estimate Next Quarter

182

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-89.2

Target Price

18.92

P/E

Forward P/E

31.19

PEG

P/S

2.16

P/B

1.58

P/Free Cash Flow

EPS

-0.62

Average EPS Est. Cur. Y

0.17

EPS Next Y. (Est.)

0.34

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.92

Relative Volume

1.98

Return on Equity vs Sector %

-28

Return on Equity vs Industry %

-19.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

NeoGenomics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 2200

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

stock quote shares NEO – Neogenomics Inc. Stock Price stock today

news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NEO – Neogenomics Inc. yahoo finance google finance

stock history NEO – Neogenomics Inc. invest stock market

stock prices NEO premarket after hours

ticker NEO fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y